Takeda Pharmaceutical Co Ltd could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from recovered patients' blood, company executives said on Wednesday.
from Reuters: Health https://ift.tt/35VDsbg
via
IFTTT
0 comments: